{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:12:25Z","timestamp":1791576745496,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00428-007-0551-z","type":"journal-article","created":{"date-parts":[[2007,12,13]],"date-time":"2007-12-13T15:09:34Z","timestamp":1197558574000},"page":"147-155","source":"Crossref","is-referenced-by-count":38,"title":["Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas"],"prefix":"10.1007","volume":"452","author":[{"given":"Hua-chuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-fu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,14]]},"reference":[{"key":"551_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tripleo.2005.06.011","volume":"101","author":"MJ Aldred","year":"2006","unstructured":"Aldred MJ, Talacko AA, Savarirayan R, Murdolo V, Mills AE, Radden BG, Alimov A, Villablanca A, Larsson C (2006) Dental findings in a family with hyperparathyroidism\u2013jaw tumour syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:212\u2013218","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"551_CR2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1209893","volume":"26","author":"KJ Bradley","year":"2007","unstructured":"Bradley KJ, Bowl MR, Williams SE, Ahmad BN, Partridge CJ, Patmanidi AL, Kennedy AM, Loh NY, Thakker RV (2007) Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene 26:1213\u20131221","journal-title":"Oncogene"},{"key":"551_CR3","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1136\/jmg.2005.032201","volume":"42","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Cavaco BM, Bowl MR, Harding B, Young A, Thakker RV (2005) Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism. J Med Genet 42:e51","journal-title":"J Med Genet"},{"key":"551_CR4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism\u2013jaw tumour syndrome. Nat Genet 32:676\u2013680","journal-title":"Nat Genet"},{"key":"551_CR5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, Marsh DJ (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism\u2212jaw tumour (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30:1140\u20131149","journal-title":"Am J Surg Pathol"},{"key":"551_CR6","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/sj.onc.1208778","volume":"24","author":"MA Hahn","year":"2005","unstructured":"Hahn MA, Marsh DJ (2005) Identification of a functional bipartite nuclear localization signal in the tumour suppressor parafibromin. Oncogene 24:6241\u20136248","journal-title":"Oncogene"},{"key":"551_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657\u2013663","journal-title":"J Med Genet"},{"key":"551_CR8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, Weber G, Hoog A, Villablanca A (2006) Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 13:509\u2013523","journal-title":"Endocr Relat Cancer"},{"key":"551_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0895-4356(02)00534-6","volume":"56","author":"JR Kelley","year":"2003","unstructured":"Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1\u20139","journal-title":"J Clin Epidemiol"},{"key":"551_CR10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1097-2765(03)00091-1","volume":"11","author":"NJ Krogan","year":"2003","unstructured":"Krogan NJ, Dover J, Wood A, Schneider J, Heidt J, Boateng MA, Dean K, Ryan OW, Golshani A, Johnston M, Greenblatt JF, Shilatifard A (2003) The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Mol Cell 11:721\u2013729","journal-title":"Mol Cell"},{"key":"551_CR11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/modpathol.3800165","volume":"17","author":"T Kumada","year":"2004","unstructured":"Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y (2004) Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5\u00a0years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17:1141\u20131149","journal-title":"Mod Pathol"},{"key":"551_CR12","first-page":"824","volume":"20","author":"T Kurokawa","year":"1967","unstructured":"Kurokawa T, Fuchigami A (1967) Gastric carcinoma in its early stages. Naika 20:824\u2013829","journal-title":"Naika"},{"key":"551_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31\u201349","journal-title":"Acta Pathol Microbiol Scand"},{"key":"551_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1541-7786.MCR-06-0129","volume":"5","author":"L Lin","year":"2007","unstructured":"Lin L, Czapiga M, Nini L, Zhang JH, Simonds WF (2007) Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism\u2013jaw tumor syndrome enhances its proapoptotic function. Mol Cancer Res 5:183\u2013193","journal-title":"Mol Cancer Res"},{"key":"551_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","volume":"125","author":"C Mosimann","year":"2006","unstructured":"Mosimann C, Hausmann G, Basler K (2006) Parafibromin\/hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/Armadillo. Cell 125:327\u2013341","journal-title":"Cell"},{"key":"551_CR16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.oraloncology.2005.11.019","volume":"42","author":"FJ Pimenta","year":"2006","unstructured":"Pimenta FJ, Gontijo Silveira LF, Tavares GC, Silva AC, Perdigao PF, Castro WH, Gomez MV, Teh BT, De Marco L, Gomez RS (2006) HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol 42:735\u2013739","journal-title":"Oral Oncol"},{"key":"551_CR17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1469-7580.2006.00657.x","volume":"209","author":"A Porzionato","year":"2006","unstructured":"Porzionato A, Macchi V, Barzon L, Masi G, Iacobone M, Parenti A, Palu G, De Caro R (2006) Immunohistochemical assessment of parafibromin in mouse and human tissues. J Anat 209:817\u2013827","journal-title":"J Anat"},{"key":"551_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","volume":"25","author":"O Rozenblatt-Rosen","year":"2005","unstructured":"Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH, Meyerson M (2005) The parafibromin tumour suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25:612\u2013620","journal-title":"Mol Cell Biol"},{"key":"551_CR19","doi-asserted-by":"crossref","unstructured":"Selvarajan S, Sii LH, Lee A, Yip G, Bay BH, Tan MH, Teh BT, Tan PH (2007) Parafibromin expression in breast cancer: a novel marker for prognostication? J Clin Pathol (in press)","DOI":"10.1136\/jcp.2007.048694"},{"key":"551_CR20","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722\u20131729","journal-title":"N Engl J Med"},{"key":"551_CR21","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind CH (2002) TNM classification of malignant tumours, 6th edn. Wiley, Hoboken","edition":"6"},{"key":"551_CR22","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"MH Tan","year":"2004","unstructured":"Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, Zhao P, Tretiakova MS, Korpi-Hyovalti E, Burgess JR, Soo KC, Cheah WK, Cao B, Resau J, Morreau H, Teh BT (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10:6629\u20136637","journal-title":"Clin Cancer Res"},{"key":"551_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-2005-870150","volume":"37","author":"PF Wang","year":"2005","unstructured":"Wang PF, Tan MH, Zhang C, Morreau H, Teh BT (2005) HRPT2, a tumour suppressor gene for hyperparathyroidism-jaw tumour syndrome. Horm Metab Res 37:380\u2013383","journal-title":"Horm Metab Res"},{"key":"551_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1097-2765(02)00802-X","volume":"11","author":"A Wood","year":"2003","unstructured":"Wood A, Krogan NJ, Dover J, Schneider J, Heidt J, Boateng MA, Dean K, Golshani A, Zhang Y, Greenblatt JF, Johnston M, Shilatifard A (2003) Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter. Mol Cell 11:267\u2013274","journal-title":"Mol Cell"},{"key":"551_CR25","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","volume":"24","author":"GE Woodard","year":"2005","unstructured":"Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF (2005) Parafibromin, product of the hyperparathyroidism\u2013jaw tumour syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. Oncogene 24:1272\u20131276","journal-title":"Oncogene"},{"key":"551_CR26","first-page":"339","volume":"11","author":"GY Yang","year":"1992","unstructured":"Yang GY, Zhang YC, Liu XD, Wu YQ, Li MS, Gong CY, Guan BW, Mi DH, Liu S (1992) Geographic pathology on the precursors of stomach cancer. J Environ Pathol Toxicol Oncol 11:339\u2013344","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"551_CR27","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","volume":"25","author":"A Yart","year":"2005","unstructured":"Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, Krek W (2005) The HRPT2 tumour suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25:5052\u20135060","journal-title":"Mol Cell Biol"},{"key":"551_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2006.08.169","volume":"350","author":"C Zhang","year":"2006","unstructured":"Zhang C, Kong D, Tan MH, Pappas DL, Wang PF, Chen J, Farber L, Zhang N, Koo HM, Weinreich M, Williams BO, Teh BT (2006) Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem Biophys Res Commun 350:17\u201324","journal-title":"Biochem Biophys Res Commun"},{"key":"551_CR29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1440-1827.2003.01542.x","volume":"53","author":"HC Zheng","year":"2003","unstructured":"Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC, Xin Y (2003) Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int 53:659\u2013666","journal-title":"Pathol Int"},{"key":"551_CR30","unstructured":"Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas. Appl Immunohistochem Mol Morphol (in press)"},{"key":"551_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jcp.2006.038778","volume":"60","author":"H Zheng","year":"2007","unstructured":"Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2007) Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 60:273\u2013277","journal-title":"J Clin Pathol"},{"key":"551_CR32","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/sj.bjc.6603425","volume":"95","author":"HC Zheng","year":"2006","unstructured":"Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y (2006) Upregulated EMMPRIN\/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 95:1371\u20131378","journal-title":"Br J Cancer"},{"key":"551_CR33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00432-006-0135-3","volume":"132","author":"H Zheng","year":"2006","unstructured":"Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y (2006) MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132:817\u2013823","journal-title":"J Cancer Res Clin Oncol"},{"key":"551_CR34","doi-asserted-by":"crossref","unstructured":"Zheng HC, Tsuneyama K, Takahashi H, Miwa S, Sugiyama T, Popivanova BK, Fujii C, Nomoto K, Mukaida N, Takano Y (2007) Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression. J Cancer Res Clin Oncol (in press)","DOI":"10.1007\/s00432-007-0310-1"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-007-0551-z.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T22:48:30Z","timestamp":1557096510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-007-0551-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,14]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1007\/s00428-007-0551-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,14]]}}}